Loading
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for ESTABLISHMENT LABS HOLDINGS INC., €22k.
Filing timeline
BuySaleNicholas Sheridan Lewin
Insider track record
Disclosed buys
12
Disclosed sells
0
Signal history
Closed purchases
Market purchases
7
Positive at T+90
100%
Median T+90
+67.7%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +99.9%Entry US$38.32 · Close at T+365 US$76.62
- +109.4%Entry US$37.95 · Close at T+365 US$79.47
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Nicholas Sheridan Lewin: trading record in brief
Filings by Nicholas Sheridan Lewin span 2 companies, the busiest being Establishment Labs Holdings Inc. and Allurion Technologies, Inc. Over a trading history stretching from 23 July 2018 to 30 September 2026, the count stands at 35 filings.
No open-market sale appears; the market trades are 12 purchases worth €460k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 18 share grants and 1 option exercise.
The median purchase comes to €32k. Of 8 purchases, 6 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.
The record was last updated on 2 October 2026 with a share grant (€22k) in Establishment Labs Holdings Inc. The last purchase on record was published on 14 August 2025, which is 436 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Nicholas Sheridan Lewin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
389 shares@ US$64.17Common SharesSEC:0001398327-26-000011:0
291 sharesCommon SharesSEC:0001398327-26-000005:0
440 shares@ US$56.780.5% of flowCommon SharesSEC:0001398327-26-000002:0
343 shares@ US$72.880.4% of flowCommon SharesSEC:0001398327-26-000001:0
609 shares@ US$40.990.4% of flowCommon SharesSEC:0001398327-25-000012:0
2,600 shares@ US$37.851.8% of flowCommon SharesSEC:0001398327-25-000010:0
Canonical exit: 12 Nov 2025 (T+90)
2,300 shares@ US$34.29551.4% of flowCommon SharesSEC:0001398327-25-000008:0
Canonical exit: 11 Nov 2025 (T+90)
585 shares@ US$42.710.4% of flowCommon SharesSEC:0001398327-25-000006:0
3,413 shares0Common SharesSEC:0001398327-25-000004:0
612 shares@ US$40.810.5% of flowCommon SharesSEC:0001398327-25-000002:0
542 shares@ US$46.070.5% of flowCommon SharesSEC:0001398327-25-000001:0
577 shares@ US$43.270.5% of flowCommon SharesSEC:0001398327-24-000007:0
550 shares@ US$45.440.5% of flowCommon SharesSEC:0001398327-24-000006:0
2,334 shares0Common SharesSEC:0001398327-24-000005:0
491 shares@ US$50.900.5% of flowCommon SharesSEC:0001398327-24-000004:0
1,931 shares@ US$25.891.0% of flowCommon SharesSEC:0001398327-24-000003:0
231 shares@ US$26.9550.1% of flowCommon SharesSEC:0001398327-23-000016:0
Canonical exit: 13 Mar 2024 (T+90)
5,000 shares@ US$22.002.1% of flowCommon SharesSEC:0001398327-23-000014:0
Canonical exit: 18 Feb 2024 (T+90)
250,000 shares@ US$18.0088.9% of flowCommon SharesSEC:0001398327-23-000012:0
45,235 shares0Common StockSEC:0000950170-23-055245:0
400 shares@ US$56.130.4% of flowCommon SharesSEC:0001398327-23-000009:0
Canonical exit: 13 Nov 2023 (T+90)
27,756 shares0Common SharesSEC:0001398327-23-000004:0
2,324 shares0Common SharesSEC:0001398327-23-000001:0
2,345 shares0Common SharesSEC:0001688757-22-000070:0
350 shares@ US$59.970.0008% mcap86.8% of flowCommon SharesSEC:0001398327-22-000004:0
Canonical exit: 15 Jun 2021 (T+90)
25 of 26 declarations
